Sotera Health (NASDAQ:SHC) Insider Michael Rutz Sells 150,000 Shares of Stock

Sotera Health Company (NASDAQ:SHC) insider Michael Rutz sold 150,000 shares of Sotera Health stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Sotera Health Trading Up 0.7%

Shares of SHC opened at $19.11 on Wednesday. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. The stock has a market cap of $5.45 billion, a PE ratio of 33.53 and a beta of 1.77. Sotera Health Company has a 1 year low of $13.09 and a 1 year high of $19.85. The stock has a 50 day simple moving average of $17.28 and a 200-day simple moving average of $16.31.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. During the same period in the prior year, the business posted $0.20 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, sell-side analysts predict that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently made changes to their positions in SHC. BlackRock Inc. bought a new stake in Sotera Health during the 2nd quarter worth about $428,635,000. Sculptor Capital LP raised its stake in shares of Sotera Health by 57.4% in the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock worth $370,440,000 after acquiring an additional 7,658,200 shares during the last quarter. Sachem Head Capital Management LP raised its stake in shares of Sotera Health by 47.2% in the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after acquiring an additional 3,735,000 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Sotera Health by 16.7% during the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares in the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Sotera Health by 1,206.2% during the fourth quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after purchasing an additional 2,644,831 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SHC has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. increased their target price on shares of Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Citigroup boosted their price target on shares of Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Friday. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price objective on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Finally, UBS Group set a $19.00 target price on shares of Sotera Health in a research note on Wednesday, June 24th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.50.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.